Irritable Bowel Syndrome Clinical Care Gaps and the Potential of Future Therapeutics Based on Peripheral Visceral Afferent Modulation. [PDF]
Clin Gastroenterol HepatolCamilleri M.
europepmc +1 more source
Therapeutic Potential of Cannabinoid Receptors Type 1 and 2-Novel Insights for Enhancing the Chance of Clinical Success. [PDF]
Pharmaceuticals (Basel)Grether U.
europepmc +1 more source
Polysialic Acid Modulation of Glutamate Receptors and Synaptic Mechanisms Underlying Neuronal Plasticity. [PDF]
NeuroSciChowdhury KU +5 more
europepmc +1 more source
Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer's disease: a review. [PDF]
Front PharmacolNtsapi C +4 more
europepmc +1 more source
The Endocannabinoid System in Neuropsychiatric Disorders: Mechanisms, Dysregulation and Therapeutic Potential. [PDF]
BiomedicinesMušić T, Turnšek TL.
europepmc +1 more source
The cannabinoid 2 (CB2) receptor is a class A GPCR in the endocannabinoid system. It is a promising target for treating neurodegenerative diseases, immune disorders, and neuropathic pain. CB2 receptors are highly distributed in the immune system and less
Lu, Mengyao
core
The Endocannabinoid System in Human Disease: Molecular Signaling, Receptor Pharmacology, and Therapeutic Innovation. [PDF]
Int J Mol SciȘerban M, Toader C, Covache-Busuioc RA.
europepmc +1 more source
Neuroprotective Role of Cannabinoid CB<sub>1</sub> and GPR55 Receptors in a Cell Model of Multiple Sclerosis. [PDF]
Mol NeurobiolMartínez-Pinilla E +7 more
europepmc +1 more source
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions. [PDF]
Liver IntLian J, Lareu RR, Patil M, Falasca M.
europepmc +1 more source
Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease. [PDF]
Int J Mol SciLian J, Patil M, Lareu RR, Falasca M.
europepmc +1 more source